Clinical Trial of New Drug for Schizophrenia. Reply
N Engl J Med
.
2021 Jun 24;384(25):e105.
doi: 10.1056/NEJMc2104965.
Authors
Steven M Paul
1
,
Alan Breier
2
,
Jeffrey A Lieberman
3
,
Stephen K Brannan
4
,
Sharon Sawchak
4
,
Andrew C Miller
4
Affiliations
1
Karuna Therapeutics, Boston, MA steve@karunatx.com.
2
Indiana University School of Medicine, Indianapolis, IN.
3
Columbia University, New York, NY.
4
Karuna Therapeutics, Boston, MA.
PMID:
34161716
DOI:
10.1056/NEJMc2104965
No abstract available
Publication types
Letter
Comment
MeSH terms
Antipsychotic Agents*
Humans
Pharmaceutical Preparations*
Schizophrenia* / drug therapy
Substances
Antipsychotic Agents
Pharmaceutical Preparations